Kamila Stawczyk‐Eder

511 total citations
40 papers, 396 citations indexed

About

Kamila Stawczyk‐Eder is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Kamila Stawczyk‐Eder has authored 40 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 20 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Kamila Stawczyk‐Eder's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (19 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). Kamila Stawczyk‐Eder is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (19 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). Kamila Stawczyk‐Eder collaborates with scholars based in Poland, Bulgaria and Ireland. Kamila Stawczyk‐Eder's co-authors include Piotr Eder, Iwona Krela‐Kaźmierczak, Liliana Łykowska‐Szuber, Krzysztof Linke, Aleksandra Szymczak‐Tomczak, Katarzyna Katulska, Agnieszka Dobrowolska, Michał Michalak, Patrycja Szachta and Marzena Skrzypczak-Zielińska and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Nutrients.

In The Last Decade

Kamila Stawczyk‐Eder

39 papers receiving 388 citations

Peers

Countries citing papers authored by Kamila Stawczyk‐Eder

Since Specialization

Citations

This map shows the geographic impact of Kamila Stawczyk‐Eder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamila Stawczyk‐Eder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamila Stawczyk‐Eder more than expected).

Fields of papers citing papers by Kamila Stawczyk‐Eder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamila Stawczyk‐Eder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamila Stawczyk‐Eder. The network helps show where Kamila Stawczyk‐Eder may publish in the future.

Co-authorship network of co-authors of Kamila Stawczyk‐Eder

This figure shows the co-authorship network connecting the top 25 collaborators of Kamila Stawczyk‐Eder. A scholar is included among the top collaborators of Kamila Stawczyk‐Eder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamila Stawczyk‐Eder. Kamila Stawczyk‐Eder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn’s disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II) 2024 ·Therapeutic Advances in Gastroenterology ·(unknown), Maria Kłopocka, Agata Michalak, Halina Cichoż‐Lach, Renata Talar‐Wojnarowska, (unknown), (unknown), (unknown), (unknown), (unknown), Kamila Stawczyk‐Eder, (unknown), (unknown), Edyta Zagórowicz, (unknown), (unknown), (unknown)	2
2	Association of the ILR1 and FAS genes variants with a primary non-response to Anti-TNF therapy in Crohn's disease patients 2023 ·Polskie Archiwum Medycyny Wewnętrznej ·Liliana Łykowska‐Szuber, Marzena Skrzypczak-Zielińska, (unknown), (unknown), Kamila Stawczyk‐Eder, Iwona Krela‐Kaźmierczak, Michał Michalak, Ryszard Słomski, Agnieszka Dobrowolska	2
3	Assessment of the activity of the immune system in patients with inflammatory bowel diseases and asymptomatic COVID-19 2023 ·Gastroenterology Review ·(unknown), (unknown), Kamila Stawczyk‐Eder, Piotr Eder, Agnieszka Dobrowolska, Maria Wiśniewska‐Jarosińska, Anita Gąsiorowska, (unknown), Grażyna Rydzewska	2
4	Atypical COVID-19 erythema nodosum in a patient with ulcerative colitis treated with Upadacitinib 2023 ·Polskie Archiwum Medycyny Wewnętrznej ·(unknown), Kamila Stawczyk‐Eder, Piotr Eder, (unknown), Agnieszka Dobrowolska, (unknown)	0
5	P421 Real-world effectiveness and safety of vedolizumab induction therapy for Crohn’s disease in Poland – a prospective, observational POLONEZ II study considering patients reported outcomes 2023 ·Journal of Crohn s and Colitis ·(unknown), Maria Kłopocka, Halina Cichoż‐Lach, (unknown), Renata Talar‐Wojnarowska, (unknown), (unknown), (unknown), (unknown), Piotr Eder, Kamila Stawczyk‐Eder, (unknown), Edyta Zagórowicz, (unknown), (unknown)	1
6	Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease 2021 ·Frontiers in Immunology ·Liliana Łykowska‐Szuber, Michał Walczak, Marzena Skrzypczak-Zielińska, (unknown), Kamila Stawczyk‐Eder, (unknown), Piotr Eder, Anna Woźniak, Iwona Krela‐Kaźmierczak, Ryszard Słomski, Agnieszka Dobrowolska	16
7	Milk and dairy product consumption in patients with inflammatory bowel disease: Helpful or harmful to bone mineral density? 2020 ·Nutrition ·Iwona Krela‐Kaźmierczak, Michał Michalak, Aleksandra Szymczak‐Tomczak, Agata Czarnywojtek, (unknown), Liliana Łykowska‐Szuber, Kamila Stawczyk‐Eder, Agnieszka Dobrowolska, Piotr Eder	9
8	Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients? 2020 ·Frontiers in Pharmacology ·Michał Walczak, Liliana Łykowska‐Szuber, (unknown), Kamila Stawczyk‐Eder, Oliwia Zakerska‐Banaszak, Piotr Eder, Iwona Krela‐Kaźmierczak, Michał Michalak, Marek Żywicki, Wojciech M. Karłowski, Marlena Szalata, Agnieszka Dobrowolska, Ryszard Słomski, Marzena Skrzypczak-Zielińska	10
9	ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s Disease 2019 ·Journal of Clinical Medicine ·Iwona Krela‐Kaźmierczak, Marzena Skrzypczak-Zielińska, Marta Kaczmarek-Ryś, Michał Michalak, Aleksandra Szymczak‐Tomczak, Szymon Hryhorowicz, Marlena Szalata, Liliana Łykowska‐Szuber, Piotr Eder, Kamila Stawczyk‐Eder, Maciej Tomczak, Ryszard Słomski, Agnieszka Dobrowolska	14
10	Vitamin D receptor (VDR) TaqI polymorphism, vitamin Dand bone mineral density in patients with inflammatory bowel diseases 2019 ·Advances in Clinical and Experimental Medicine ·Aleksandra Szymczak‐Tomczak, Iwona Krela‐Kaźmierczak, Marta Kaczmarek-Ryś, Szymon Hryhorowicz, Kamila Stawczyk‐Eder, Marlena Szalata, Marzena Skrzypczak-Zielińska, Liliana Łykowska‐Szuber, Piotr Eder, Michał Michalak, Agnieszka Dobrowolska, Ryszard Słomski	8
11	Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs 2018 ·The Pharmacogenomics Journal ·Michał Walczak, Marzena Skrzypczak-Zielińska, (unknown), Oliwia Zakerska‐Banaszak, (unknown), Liliana Łykowska‐Szuber, Kamila Stawczyk‐Eder, Agnieszka Dobrowolska, Ryszard Słomski	10
12	An increase in serum tumour necrosis factor-α during anti-tumour necrosis factor-α therapy for Crohn's disease – A paradox or a predictive index? 2016 ·Digestive and Liver Disease ·Piotr Eder, Katarzyna Korybalska, Liliana Łykowska‐Szuber, Kamila Stawczyk‐Eder, Iwona Krela‐Kaźmierczak, (unknown), (unknown), Krzysztof Linke, Janusz Witowski	10
13	Disturbances in apoptosis of lamina propria lymphocytes in Crohn’s disease 2015 ·Archives of Medical Science ·Piotr Eder, Liliana Łykowska‐Szuber, Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, (unknown), Przemysław Majewski, Karolina Sterzyńska, M. Zabel, Krzysztof Linke	10
14	Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn’s disease 2015 ·Cytokine ·Piotr Eder, Katarzyna Korybalska, Liliana Łykowska‐Szuber, Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, (unknown), Aleksandra Szymczak‐Tomczak, Krzysztof Linke, Janusz Witowski	8
15	The influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn’s disease patients in relation to mucosal healing 2015 ·Folia Histochemica et Cytobiologica ·Piotr Eder, Liliana Łykowska‐Szuber, (unknown), Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, Przemysław Majewski, Krzysztof Linke, Elaine W. Kay, Aldona Woźniak	13
16	Diagnostic importance of faecal markers in long-term monitoring of anti-TNF- therapy in primary responders with Crohn’s disease 2015 ·Gastroenterology Review ·Liliana Łykowska‐Szuber, (unknown), Piotr Eder, Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, Michał Michalak, Adam Studniarek, (unknown), Aleksandra Szymczak‐Tomczak, Krzysztof Linke	3
17	The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity 2015 ·Abdominal Imaging ·Piotr Eder, Katarzyna Katulska, Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, (unknown), Aleksandra Szymczak‐Tomczak, Krzysztof Linke, Liliana Łykowska‐Szuber	21
18	Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn’s disease naive to anti-TNF agents 2015 ·Gastroenterology Review ·Piotr Eder, Liliana Łykowska‐Szuber, Katarzyna Katulska, Kamila Stawczyk‐Eder, Iwona Krela‐Kaźmierczak, (unknown), Aleksandra Szymczak‐Tomczak, (unknown), Krzysztof Linke	21
19	Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases 2014 ·Gastroenterology Review ·Piotr Eder, Liliana Łykowska‐Szuber, Kamila Stawczyk‐Eder, Iwona Krela‐Kaźmierczak, Krzysztof Linke	6
20	Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn’s disease 2013 ·Folia Histochemica et Cytobiologica ·Piotr Eder, Liliana Łykowska‐Szuber, Iwona Krela‐Kaźmierczak, Kamila Stawczyk‐Eder, Karolina Sterzyńska, (unknown), Przemysław Majewski, M. Zabel, Krzysztof Linke	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact